| |
|
|
|
|
Maxygen, Inc.(MAXY)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
Goldman, Sachs & Co.
|
| |
|
|
Robertson, Stephens & Company
|
| Status: |
|
|
Invemed Associates
|
| |
| Address: |
515 Galveston Drive
|
FiledDate: |
|
| |
|
|
|
| |
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
(650) 298-5300 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
(650) 364-2715 |
Shares Offered (Millions): |
6,000,000 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
29,910,568 |
| |
|
|
|
| Management: |
Russell J. Howard, Pres./CEO/Dir.
|
IPO Date: |
|
| |
Simba Gill, CFO
|
|
|
| |
Isaac Stein, Chairman
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
|
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
126 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
Diversa
|
S-1 Forms: |
|
| |
Ixsys
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 1997
|
341 |
3672 |
-3331 |
0.00 |
-3170 |
-.64 |
| 1998
|
5210 |
10194 |
-4984 |
0.00 |
-4755 |
-.7 |
| 1999
|
9318 |
16175 |
-6857 |
0.00 |
-6074 |
-.78 |
| * Nine Months ended September 30, 1999
| |
|
|
|
|
|
|
| |
|
| |
|
|
